Description

Patent-pending enzymes to break down common dietary triggersKiwi Biosciences can help 18M Americans suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without running to the bathroom two hours later. We develop novel, patent-pending enzymes that break down common digestive triggers in food.

 


ACTIVE FOUNDERS

Founder 1

David Hachuel,

Formerly co-founder and CEO at auggi.ai, a digital gut health coach for patients with Irritable Bowel Syndrome (IBS). auggi was recently acquired by Seed Health. Completed my MPH in Epidemiology at the Harvard School of Public Health and a Master's in Computer and Information Science at Cornell University.

Twitter: | Linkedin: https://www.linkedin.com/in/david-hachuel/


Founder 2

Anjie Liu,

Interdisciplinary thinker: scientifically-minded; humanist at heart Joint concentration in physics and comparative literature (Harvard 2017), now submerging myself into the intricate world of biology. I've struggled with chronic gut issues for most of my adult life, which led me to developing the current formulation of FODZYME and launching Kiwi Biosciences.

Twitter: | Linkedin: https://www.linkedin.com/in/anjie-liu


Founder 3

,

Twitter: | Linkedin:


Founder 4

,

Twitter: | Linkedin:


Founder 5

,

Twitter: | Linkedin:


Founder 6

,

Twitter: | Linkedin:

Based in
Nation
Founded in

2020

Team Size

6

Not Available
Today's work schedule is not available
  • Monday

    By appointment only

  • Tuesday

    N/A

  • Wednesday

    N/A

  • Thursday

    N/A

  • Friday

    N/A

  • Saturday

    N/A

  • Sunday

    N/A

  • 9 December 2022 23:19 local time

mood_bad
  • No comments yet.
  • Add a review
      error: Content protected